VTGN (STOCKS)
Vistagen Therapeutics, Inc. Common Stock
$0.570100
-0.006100 (-1.06%)
Prev close: $0.576200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Shawn K. Singh
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $22.70M
- Employees
- 57
- P/E (TTM)
- -0.36
- P/B (TTM)
- 0.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
7
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q4)
|
$-0.37 | $-0.34 | -0.0266 | -7.75% |
|
Dec 2025 (Q3)
|
$-0.45 | $-0.50 | +0.0457 | +9.22% |
|
Sep 2025 (Q2)
|
$-0.54 | $-0.49 | -0.0545 | -11.23% |
|
Jun 2025 (Q1)
|
$-0.47 | $-0.48 | +0.0128 | +2.65% |
Financial Statements
| Revenues | $789.00K |
| Benefits Costs and Expenses | $67.84M |
| Costs And Expenses | $67.84M |
| Operating Expenses | $70.69M |
| Research and Development | $52.02M |
| Other Operating Expenses | $18.57M |
| Operating Income/Loss | -$69.90M |
| Income/Loss From Continuing Operations After Tax | -$67.05M |
| Income/Loss From Continuing Operations Before Tax | -$67.05M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$67.05M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$67.05M |
| Net Income/Loss Available To Common Stockholders, Basic | -$67.05M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.90 |
| Diluted Earnings Per Share | -$1.91 |
| Basic Average Shares | 36,882,840 |
| Diluted Average Shares | 76,312,396 |
| Assets | $65.06M |
| Current Assets | $63.25M |
| Cash | $61.80M |
| Other Current Assets | $1.45M |
| Noncurrent Assets | $1.81M |
| Fixed Assets | $480.00K |
| Other Non-current Assets | $1.33M |
| Liabilities | $14.14M |
| Current Liabilities | $13.53M |
| Accounts Payable | $1.28M |
| Other Current Liabilities | $12.25M |
| Noncurrent Liabilities | $607.00K |
| Equity | $50.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $50.92M |
| Liabilities And Equity | $65.06M |
| Net Cash Flow From Operating Activities | -$60.30M |
| Net Cash Flow From Operating Activities, Continuing | -$60.30M |
| Net Cash Flow From Investing Activities | -$251.00K |
| Net Cash Flow From Investing Activities, Continuing | -$251.00K |
| Net Cash Flow From Financing Activities | $33.21M |
| Net Cash Flow From Financing Activities, Continuing | $33.21M |
| Net Cash Flow | -$27.34M |
| Net Cash Flow, Continuing | -$27.34M |
| Comprehensive Income/Loss | -$67.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$67.04M |
| Other Comprehensive Income/Loss | -$67.04M |